About 2 Mg Bortezomib Injection IP
Our 2 Mg Bortezomib Injection IP offers a potent therapeutic solution at a reduced and cost-effective price point, making it a true bargain for healthcare providers. Renowned for its efficacy as a distinguished proteasome inhibitor, this injection is formulated as a lyophilized powder for convenient reconstitution. Designed for intravenous or subcutaneous administration, Bortezomib 2 mg demonstrates strong enzymatic activity by inhibiting 26S proteasome activity. Suitable for patients with multiple myeloma and mantle cell lymphoma, it is supplied in a single dose vial and should be stored below 25C, protected from light.
Key Applications and Material Features
2 Mg Bortezomib Injection IP is used for the treatment of multiple myeloma and mantle cell lymphoma, providing reliable results for oncological care. Its lyophilized powder format ensures stability and ease of preparation. The injection is intended for both intravenous and subcutaneous media, ensuring versatility in administration and effective therapeutic outcomes for practitioners and patients alike.
Sample Availability, FOB Port, and Packaging Details
Samples of 2 Mg Bortezomib Injection IP are available upon request, allowing for informed purchases. Shipments can be arranged via the specified FOB port, with robust packaging designed to prevent contamination or damage during transit. Each order is securely packaged and shipped with care, with charges tailored to the quantity and destination requirements for seamless trading.
FAQ's of 2 Mg Bortezomib Injection IP:
Q: How is 2 Mg Bortezomib Injection IP administered?
A: The injection can be given intravenously or subcutaneously, depending on the physician's guidance and patient-specific requirements.
Q: What conditions is Bortezomib Injection IP commonly used to treat?
A: It is primarily indicated for the treatment of multiple myeloma and mantle cell lymphoma.
Q: When should the reconstituted injection be used?
A: Once reconstituted with 0.9% Sodium Chloride, the clear and colorless solution should be used promptly as directed to maintain its efficacy.
Q: Where should the product be stored?
A: It should be stored below 25C and protected from light to ensure its potency and prolong shelf life.
Q: What are the benefits of the lyophilized powder formulation?
A: The lyophilized powder format enhances the drug's stability during storage and transport, and simplifies preparation before administration.